triple g retatrutide is a “triple agonist” (often called “triple G”) that works by mimicking three hormones—GLP-1, GIP, and glucagon—to manage weight and metabolism. It reduces appetite and slows digestion, increases energy expenditure to Medical breakthrough in new weight-loss

Swanson *These statements have not been evaluated by the Food and Drug Administration

References Glucagon-like peptide 1-based therapies for the treatment of type 2 diabetes mellitus UpToDate accessed 5/11/24 GLP-1 receptor agonists | Prescribing information | Diabetes type 2 | CKS | NICE Bydureon 2 mg prolonged release suspension for injection in pre-filled pen (BCise) Summary of Product Characteristics (SmPC) (emc) Victoza 6 mg/ml solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) TRULICITY 1.5 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Ozempic 0.25 mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc) Mounjaro KwikPen 10mg solution for injection in pre-filled pen Summary of Product Characteristics (SmPC) (emc)

"So to double the dose of a drug acting on these pathways, we know for certain with similar drugs like steroids, that it can have drastic effects on the body." He said in the controlled environment of clinical trials, retatrutide was showing "some positive effects", but unapproved peptides bought online could contain incorrect dosing and contaminants

GLP-1 medications are typically ongoing monthly expenses rather than one-time treatments

As many as 24% to 44% of people experience nausea on semaglutide and tirzepatide

In treated donors, L